• Title/Summary/Keyword: Deuk-shin Kim

Search Result 165, Processing Time 0.06 seconds

A Study on the Reading King, Deuk-shin Kim's Doksoogi (독서왕 김득신의 「독수기(讀數記)」에 대한 연구)

  • Han, Mi-kyung
    • Journal of the Korean Society for Library and Information Science
    • /
    • v.49 no.1
    • /
    • pp.423-441
    • /
    • 2015

  • The results of this study are as follows. Firstly, out of existing manuscripts of Baeggokjib, the one possessed by Sang-hyun Kim and the one possessed by Jonkyunggak, Sungkyunkwan University shows reading reaords. Secondly, as a result of the analyses of the differences between Doksoogi and Gomoonsamshibyookdoksoogi, in terms of 1) order of records 2) the difference in the number of old texts included in the mentioned reading records 3) the difference in the title of old text, 4) the difference in records of reading times, they were revised and rearranged to Doksoogi after the record of Gomoonsamshibyookdoksoogi. Thirdly, as a result of investigations and analyses of 36 types of old texts recorded in Dogsoogi, it was found out that 1) in terms of contents, he mainly read literary books 2) in terms of style of literary books, he read mainly prose, preface, epistle, idle stories, funeral orations, etc. 3) in terms of authors, he read the old texts of Han Yoo who was the literary person during Tang Dynasty 4) Deuk-shin Kim read tend to read mainly old texts instead of single books.

  • https://doi.org/10.4275/KSLIS.2015.49.1.423 인용 PDF KSCI

A Case of End-stage non-small cell Lung Cancer Patient with Brain Metastasis Treated with Pembrolizumab with Integrative Medicine Therapy (Pembrolizumab과 통합의학치료로 호전된 뇌전이 동반 말기 비소세포성 폐암 환자 1례)

  • Seo, Han Gil;Jin, Yong Jae;Song, Mi Hwa;Kim, In Tae;Park, Ji Hye;Jung, Jun Suk;Cho, Sung Kyoo;Shin, Kwang Soon
    • Journal of Korean Traditional Oncology
    • /
    • v.23 no.2
    • /
    • pp.11-25
    • /
    • 2018

  • Objective: The purpose of this study is to report the case of a patient with non-small cell lung cancer (NSCLC) with Programmed cell death protein 1 (PD-1) mutation treated by Integrative Medicine Therapy (IMT). Methods: A patient with metastatic NSCLC received pembrolizumab 200mg intravenously for every 3 weeks from July 2017. Repeat cycle every 3 weeks since July 2017. The patient has been treated with Integrative Medicine Therapy (IMT) since December 2016. The tumor size was measured by computed tomography (CT) and magnetic resonance imaging(MRI). Adverse events were evaluated by the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE), version 5.0. Results: After combined treatment, the extent of proximal portion of primary tumor in the left lower lobe was decreased and disease status was stable radiologically. No evidence of newly developed metastatic lesions in the brain since May 2017. The patient did not experience any adverse event according to NCI-CTCAE ver. 5.0. Conclusion: This case study suggests that Integrative Medicine Therapy (IMT) may contribute to tumor response, in conjunction with Pembrolizumab on the treatment of patients with NSCLC.

  • https://doi.org/10.15432/JKTO.2018.23.2.011 인용 PDF HTML

A Triterpene Glucosyl Ester from the Roots of Rubus crataesifolius

  • Jung, Sung-Wook;Shin, Myung-Hee;Jung, Jee-H.;Kim, Nam-Deuk;Im, Kwang-Sik
    • Archives of Pharmacal Research
    • /
    • v.24 no.5
    • /
    • pp.412-415
    • /
    • 2001

  • Along with five known triterpene glycosides, a new triterpene glucosyl ester, named crataegioside, was isolated from the roots of Rubus crataesifolius Bunge. The structure was established as ilexosapogenin A 28-O-$\beta$-D-glucopyranosyl ester by chemical and spectroscopic methods.

  • PDF